Featured Product Portfolio & Manufacturing Capabilities
Explore our certified wholesale contact lens lines available for OEM/ODM private label packaging, custom color matrixes, and global export qualification.
1. Technical Engineering of Full & Mini Sclera Contact Lenses
Sclera contact lenses represent the zenith of ophthalmic lens engineering and specialized cosmetic optics. Unlike standard soft contact lenses that rest directly on the sensitive corneal epithelium (typically measuring between 13.8mm and 14.5mm in diameter), full sclera lenses (22.0mm to 24.0mm) and mini-sclera lenses (15.0mm to 18.0mm) are geometrically engineered to vault entirely over the cornea and limbus, resting smoothly on the less sensitive conjunctiva overlying the sclera.
At BLMG Optical.Ltd., our proprietary OEM/ODM manufacturing infrastructure integrates precision computer-numerical-control (CNC) lathe-cutting with high-resolution cast-molding to produce scleral lenses that deliver structural integrity, dynamic tear exchange, and complete physiological ocular safety. Scleral vaulting requires exacting micro-curvature calibration to maintain a tear-filled fluid reservoir between the posterior lens surface and the cornea. This fluid layer continuously hydrates the ocular surface, neutralizes corneal irregularities, and provides unmatched visual clarity and wearing comfort even during prolonged wear cycles.
OEM Core Technical Insight: The stability of a 22.0mm full sclera lens relies heavily on its sagittal depth calculation. Our factory utilizes high-precision optical coherence tomography (OCT) mapping data to formulate base curves that eliminate limbal compression and prevent peripheral vascular blanching.
Sandwich Color-Locking Technology
Our bio-compatible 3-layer encapsulation process isolates non-toxic visual pigments between two inert hydrogel polymers. This completely prevents raw dye materials from contacting corneal tissues, protecting against cytotoxicity and fading.
High Oxygen Permeability (Dk/t)
Utilizing high-Dk silicone hydrogel and fluorosilicone acrylate matrix formulations, BLMG scleral lenses ensure high trans-lens oxygen flux to maintain corneal aerobic metabolism and combat hypoxia during extended daily wear.
Edge Profile Optimization
Precision-molded smooth bevel edges facilitate natural eyelid movement over the lens surface, minimizing mechanical friction, eyelid awareness, and foreign body sensation for theatrical and cosmetic users alike.
2. Structural Comparison & Specification Matrix
B2B procurement teams, optical brand directors, and medical distributors must align product specifications with target customer demographics and regulatory compliance thresholds. Below is a comparative breakdown of key manufacturing parameters across our main product lines:
| Lens Classification | Overall Diameter (Dia) | Base Curve (BC) Range | Water Content | Material Formulation | Target Channel Application |
|---|---|---|---|---|---|
| Full Sclera Lenses | 22.0mm – 24.0mm | 8.6mm – 11.0mm (Vault) | 38% – 42% | PolyHEMA / Silicone Hydrogel | Theatrical, Film Production, Special FX, Extreme Cosplay |
| Mini Sclera Lenses | 15.0mm – 18.0mm | 8.5mm – 9.2mm | 38% – 45% | Hydrophilic HEMA-NVP Polymer | Cosplay, Novelty Beauty, Anime & Character Transformation |
| Natural Cosmetic Contacts | 14.0mm – 14.5mm | 8.5mm – 8.6mm | 38% – 55% | Non-Ionic Hydrogel / SiHy | Daily Beauty Retail, E-Commerce, Optical Chains, Pharmacy |
| Prescription Toric/Rx Lenses | 14.0mm – 14.2mm | 8.4mm – 8.7mm | 38% – 48% | High-Dk Silicone Hydrogel | Optical Clinics, Vision Correction, Astigmatism & Hyperopia |
3. Global Procurement Trends in Sclera & Color Contact Lenses (2025–2030)
As the international contact lens landscape evolves, brand owners and optical importers must navigate shifting market dynamics driven by consumer preferences, technological breakthroughs, and stringent medical device oversight. BLMG Optical’s market intelligence identifies three decisive procurement trends shaping the future of sclera and color contact lens manufacturing:
Trend 1: Micro-Batch OEM Agility & Low MOQ Private Label Programs
Traditional medical device contract manufacturing historically demanded high minimum order quantities (MOQs) starting at 5,000 to 10,000 pairs per SKU, creating severe capital barriers for emerging boutique brands, niche cosplayers, and indie beauty labels. The global market is rapidly transitioning toward high-agility, small-batch OEM programs. BLMG Optical leads this shift by offering private-label customization starting at just 100 pairs per design. Flexible modular manufacturing allows brand owners to validate market demand, run seasonal collections, and minimize inventory holding risks without compromising on manufacturing standards or regulatory compliance.
Trend 2: Transition from PolyHEMA to Advanced Silicone Hydrogel Formulations
While traditional 2-hydroxyethyl methacrylate (PolyHEMA) hydrogel remains a cost-effective standard for short-wear cosmetic lenses, international buyer demand is shifting heavily toward Silicone Hydrogel (SiHy). SiHy lenses offer significantly higher oxygen transmissibility (Dk/t values exceeding 80–120 Dk/t compared to 15–20 Dk/t in conventional hydrogels). For scleral and enlarged diameter contact lenses, where lens thickness and total ocular coverage are greater, high Dk/t rates are paramount to prevent corneal swelling (edema), neovascularization, and hyperemia. Modern B2B buyers are increasingly prioritizing SiHy formulations to differentiate their brand proposition as a premium, health-first optical choice.
Trend 3: Strict Regulatory Oversight and UDI Compliance
Regulatory authorities worldwide—including the US FDA, European Medicines Agency (EU MDR 2017/745), and China NMPA—classify colored contact lenses and scleral lenses as Class III Medical Devices, regardless of whether they convey refractive optical power or are worn purely for cosmetic purposes. Importers now demand full supply-chain transparency, including Unique Device Identification (UDI) tracking, ISO 10993 biocompatibility testing reports, and ISO 13485 quality system certification. Contract manufacturers capable of providing end-to-end regulatory technical documentation, certificate of analysis (COA) per batch, and custom compliant sterile packaging (vials or blister packs) will dominate global procurement partnerships.
4. Future Technological Development Roadmap: Next-Gen Manufacturing
BLMG Optical invests continuously in cutting-edge R&D to bridge the gap between aesthetic visual artistry and advanced clinical optometry. Our technological roadmap focuses on three core pillars:
A. Automated Optical Inspection (AOI) & AI Pattern Printing
To ensure 100% color consistency and pattern alignment across multi-thousand unit production runs, BLMG is implementing automated machine-vision inspection systems. High-resolution sensors scan every individual lens post-printing to detect micro-defects, color bleed, or structural asymmetry down to 5 microns, automatically rejecting non-conforming units prior to hydration and autoclaving.
B. MPC Moisture-Retaining Surface Polymerization
By grafting 2-methacryloyloxyethyl phosphorylcholine (MPC) synthetic bio-polymers onto the lens surface, we create a biomimetic layer that mimics the cell membranes of human eyes. This technology dramatically reduces lipid and protein adsorption, decreases surface friction, and extends wearing comfort to 16+ continuous hours without dryness or surface fogging.
C. Digital Micro-Injection Printing for Hyper-Realistic Iris Textures
Moving beyond traditional pad printing techniques, our proprietary digital micro-injection technology enables 3D layered dot-matrix color application. This allows for intricate radial striations, limbal rings, and multi-tonal depth that replicates natural human iris morphology with unprecedented realism in both cosmetic and full sclera effect lenses.
5. Enterprise Factory Strengths & Quality Compliance System
BLMG Optical.Ltd. operates as a fully integrated, state-of-the-art contact lens manufacturer, merging advanced material synthesis, automated molding, custom graphic artwork design, and medical packaging under one unified management system.
GMP Cleanroom Facility
Our production floor spans cleanroom environments operating under strict ISO 7 / ISO 8 standards, featuring continuous HEPA air filtration, positive pressure control, and automated environmental monitoring to guarantee zero biological contamination.
ISO 13485 Certified QMS
Every step of our manufacturing workflow—from raw monomer synthesis to steam autoclave sterilization—is governed by an ISO 13485 certified Quality Management System, fully compliant with FDA, CE, and NMPA standards.
Turnkey Private Label Branding
We provide comprehensive OEM packaging solutions: custom designed foil blister packs, glass sterile vials, outer retail box printing, barcode creation, and compliance labeling tailored for seamless international customs clearance.
Frequently Asked Questions for B2B Importers & Brand Buyers
Critical operational, technical, and regulatory answers to assist your procurement team in qualifying BLMG Optical as your primary OEM/ODM supplier.
OEM (Original Equipment Manufacturing): We manufacture lenses according to your proprietary artwork designs, unique dimensional specifications, target water content, or physical sample matching.
Partner with a Leading Sclera Contact Lens Manufacturer
Launch your brand or expand your optical catalog with our ISO 13485 certified factory. Request product samples, custom OEM quotes, or technical documentation today.